 | • レポートコード：QY20ST-05200 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の組換えタンパク質ワクチン市場について種類別（バクテリア細胞培養、哺乳類細胞培養）、用途別（人間、動物）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換えタンパク質ワクチン市場の概要 ・世界の主要地域別組換えタンパク質ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換えタンパク質ワクチン市場規模2015-2026：種類別（バクテリア細胞培養、哺乳類細胞培養） ・世界の組換えタンパク質ワクチン市場規模2015-2026：用途別（人間、動物） ・組換えタンパク質ワクチンの北米市場規模2015-2020 ・組換えタンパク質ワクチンのヨーロッパ市場規模2015-2020 ・組換えタンパク質ワクチンの中国市場規模2015-2020 ・組換えタンパク質ワクチンの日本市場規模2015-2020 ・組換えタンパク質ワクチンの東南アジア市場規模2015-2020 ・組換えタンパク質ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換えタンパク質ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換えタンパク質ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Recombinant Protein Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Recombinant Protein Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Recombinant Protein Vaccine refers to the vaccines manufactured using recombinant DNA technology
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Recombinant Protein Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Recombinant Protein Vaccine industry.
Based on our recent survey, we have several different scenarios about the Recombinant Protein Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Recombinant Protein Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Recombinant Protein Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Recombinant Protein Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Recombinant Protein Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Recombinant Protein Vaccine market. The report also includes nautical information, where it shows Recombinant Protein Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Recombinant Protein Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Recombinant Protein Vaccine market.
Geographical Analysis:
Based on region, the global Recombinant Protein Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Recombinant Protein Vaccine market are
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Novavax
Medicago
Segment by Type
Bacterial Cells Culture
Mammalian Cells Culture
Segment by Application
Human
Animal
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Recombinant Protein Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Recombinant Protein Vaccine market.
• The market share of the global Recombinant Protein Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Recombinant Protein Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Recombinant Protein Vaccine market.
1 Recombinant Protein Vaccine Market Overview
1.1 Recombinant Protein Vaccine Product Scope
1.2 Recombinant Protein Vaccine Segment by Type
1.2.1 Global Recombinant Protein Vaccine Sales by Type (2020-2026)
1.2.2 Bacterial Cells Culture
1.2.3 Mammalian Cells Culture
1.3 Recombinant Protein Vaccine Segment by Application
1.3.1 Global Recombinant Protein Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Human
1.3.3 Animal
1.4 Recombinant Protein Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Protein Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Protein Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Protein Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Recombinant Protein Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Recombinant Protein Vaccine Industry
1.5.1.1 Recombinant Protein Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Recombinant Protein Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Recombinant Protein Vaccine Players to Combat Covid-19 Impact
2 Recombinant Protein Vaccine Estimate and Forecast by Region
2.1 Global Recombinant Protein Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Protein Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Protein Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Protein Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Protein Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Protein Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Protein Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Protein Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Protein Vaccine Estimates and Projections (2015-2026)
2.4.3 China Recombinant Protein Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Protein Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Protein Vaccine Estimates and Projections (2015-2026)
2.4.6 India Recombinant Protein Vaccine Estimates and Projections (2015-2026)
3 Global Recombinant Protein Vaccine Competition Landscape by Players
3.1 Global Top Recombinant Protein Vaccine Players by Sales (2015-2020)
3.2 Global Top Recombinant Protein Vaccine Players by Revenue (2015-2020)
3.3 Global Recombinant Protein Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Vaccine as of 2019)
3.4 Global Recombinant Protein Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Protein Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Protein Vaccine Players (Opinion Leaders)
4 Global Recombinant Protein Vaccine Market Size by Type
4.1 Global Recombinant Protein Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Protein Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Protein Vaccine Price by Type (2014-2020)
4.2 Global Recombinant Protein Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Protein Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Protein Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Protein Vaccine Price Forecast by Type (2021-2026)
5 Global Recombinant Protein Vaccine Market Size by Application
5.1 Global Recombinant Protein Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Protein Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Protein Vaccine Price by Application (2015-2020)
5.2 Global Recombinant Protein Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Protein Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Protein Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Protein Vaccine Price Forecast by Application (2021-2026)
3 North America Recombinant Protein Vaccine Market Facts & Figures
3.2 North America Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
4 Europe Recombinant Protein Vaccine Market Facts & Figures
4.2 Europe Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
5 China Recombinant Protein Vaccine Market Facts & Figures
5.2 China Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
5.3 China Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
5.4 China Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
6 Japan Recombinant Protein Vaccine Market Facts & Figures
6.2 Japan Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Recombinant Protein Vaccine Market Facts & Figures
7.2 Southeast Asia Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
8 India Recombinant Protein Vaccine Market Facts & Figures
8.2 India Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
8.3 India Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
8.4 India Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Protein Vaccine Business
12.1 Merck
12.1.1 Merck Recombinant Protein Vaccine Corporation Information
12.1.2 Merck Recombinant Protein Vaccine Business Overview and Total Revenue
12.1.3 Merck Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Recombinant Protein Vaccine Products Offered
12.1.5 Merck Recent Development
12.2 GSK
12.2.1 GSK Recombinant Protein Vaccine Corporation Information
12.2.2 GSK Recombinant Protein Vaccine Business Overview and Total Revenue
12.2.3 GSK Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Recombinant Protein Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi
12.3.1 Sanofi Recombinant Protein Vaccine Corporation Information
12.3.2 Sanofi Recombinant Protein Vaccine Business Overview and Total Revenue
12.3.3 Sanofi Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Recombinant Protein Vaccine Products Offered
12.3.5 Sanofi Recent Development
12.4 Zoties
12.4.1 Zoties Recombinant Protein Vaccine Corporation Information
12.4.2 Zoties Recombinant Protein Vaccine Business Overview and Total Revenue
12.4.3 Zoties Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Zoties Recombinant Protein Vaccine Products Offered
12.4.5 Zoties Recent Development
12.5 Elanco
12.5.1 Elanco Recombinant Protein Vaccine Corporation Information
12.5.2 Elanco Recombinant Protein Vaccine Business Overview and Total Revenue
12.5.3 Elanco Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Elanco Recombinant Protein Vaccine Products Offered
12.5.5 Elanco Recent Development
12.6 Boehringer-Ingelheim
12.6.1 Boehringer-Ingelheim Recombinant Protein Vaccine Corporation Information
12.6.2 Boehringer-Ingelheim Recombinant Protein Vaccine Business Overview and Total Revenue
12.6.3 Boehringer-Ingelheim Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Boehringer-Ingelheim Recombinant Protein Vaccine Products Offered
12.6.5 Boehringer-Ingelheim Recent Development
12.7 Indian Immunologicals
12.7.1 Indian Immunologicals Recombinant Protein Vaccine Corporation Information
12.7.2 Indian Immunologicals Recombinant Protein Vaccine Business Overview and Total Revenue
12.7.3 Indian Immunologicals Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Indian Immunologicals Recombinant Protein Vaccine Products Offered
12.7.5 Indian Immunologicals Recent Development
12.8 Plumbline Life Sciences
12.8.1 Plumbline Life Sciences Recombinant Protein Vaccine Corporation Information
12.8.2 Plumbline Life Sciences Recombinant Protein Vaccine Business Overview and Total Revenue
12.8.3 Plumbline Life Sciences Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Plumbline Life Sciences Recombinant Protein Vaccine Products Offered
12.8.5 Plumbline Life Sciences Recent Development
12.9 Novavax
12.9.1 Novavax Recombinant Protein Vaccine Corporation Information
12.9.2 Novavax Recombinant Protein Vaccine Business Overview and Total Revenue
12.9.3 Novavax Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novavax Recombinant Protein Vaccine Products Offered
12.9.5 Novavax Recent Development
12.10 Medicago
12.10.1 Medicago Recombinant Protein Vaccine Corporation Information
12.10.2 Medicago Recombinant Protein Vaccine Business Overview and Total Revenue
12.10.3 Medicago Recombinant Protein Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Medicago Recombinant Protein Vaccine Products Offered
12.10.5 Medicago Recent Development
13 Recombinant Protein Vaccine Manufacturing Cost Analysis
13.1 Recombinant Protein Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Protein Vaccine
13.4 Recombinant Protein Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Protein Vaccine Distributors List
14.3 Recombinant Protein Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Protein Vaccine Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Recombinant Protein Vaccine Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Recombinant Protein Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Recombinant Protein Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Recombinant Protein Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Recombinant Protein Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Recombinant Protein Vaccine Sales (K Units) by Region (2015-2020)
Table 10. Global Recombinant Protein Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Recombinant Protein Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Recombinant Protein Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Recombinant Protein Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Recombinant Protein Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Recombinant Protein Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Recombinant Protein Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Recombinant Protein Vaccine (K Units) of Key Companies (2015-2020)
Table 18. Global Recombinant Protein Vaccine Sales Share by Company (2015-2020)
Table 19. Global Recombinant Protein Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Recombinant Protein Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Recombinant Protein Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Vaccine as of 2019)
Table 22. Global Recombinant Protein Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Recombinant Protein Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Recombinant Protein Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Recombinant Protein Vaccine Players
Table 27. Global Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 28. Global Recombinant Protein Vaccine Sales Share by Type (2015-2020)
Table 29. Global Recombinant Protein Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Recombinant Protein Vaccine Price (K Units) by Type (2015-2020)
Table 31. Global Recombinant Protein Vaccine Sales Share by Type (2021-2026)
Table 32. Global Recombinant Protein Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Recombinant Protein Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Recombinant Protein Vaccine Price (K Units) by Type (2021-2026)
Table 35. Global Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 36. Global Recombinant Protein Vaccine Sales Share by Application (2015-2020)
Table 37. Global Recombinant Protein Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Recombinant Protein Vaccine Price (K Units) by Application (2015-2020)
Table 39. Global Recombinant Protein Vaccine Sales (K Units) by Application (2021-2026)
Table 40. Global Recombinant Protein Vaccine Sales Share by Application (2021-2026)
Table 41. Global Recombinant Protein Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Recombinant Protein Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Recombinant Protein Vaccine Price (K Units) by Application (2021-2026)
Table 44. United States Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 45. United States Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 47. United States Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 49. United States Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 51. Europe Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 53. Europe Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 55. Europe Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 57. China Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 59. China Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 61. China Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 63. Japan Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 65. Japan Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 67. Japan Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Recombinant Protein Vaccine Sales (K Units) by Company (2015-2020)
Table 75. India Recombinant Protein Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Recombinant Protein Vaccine Sales (K Units) by Type (2015-2020)
Table 77. India Recombinant Protein Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Recombinant Protein Vaccine Sales (K Units) by Application (2015-2020)
Table 79. India Recombinant Protein Vaccine Sales Market Share by Application (2015-2020)
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Recombinant Protein Vaccine Product
Table 84. Merck Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Recombinant Protein Vaccine Product
Table 89. GSK Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Sanofi Recombinant Protein Vaccine Product
Table 94. Sanofi Recent Development
Table 95. Zoties Corporation Information
Table 96. Zoties Description and Business Overview
Table 97. Zoties Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Zoties Recombinant Protein Vaccine Product
Table 99. Zoties Recent Development
Table 100. Elanco Corporation Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Elanco Recombinant Protein Vaccine Product
Table 104. Elanco Recent Development
Table 105. Boehringer-Ingelheim Corporation Information
Table 106. Boehringer-Ingelheim Description and Business Overview
Table 107. Boehringer-Ingelheim Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Boehringer-Ingelheim Recombinant Protein Vaccine Product
Table 109. Boehringer-Ingelheim Recent Development
Table 110. Indian Immunologicals Corporation Information
Table 111. Indian Immunologicals Description and Business Overview
Table 112. Indian Immunologicals Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Indian Immunologicals Recombinant Protein Vaccine Product
Table 114. Indian Immunologicals Recent Development
Table 115. Plumbline Life Sciences Corporation Information
Table 116. Plumbline Life Sciences Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Plumbline Life Sciences Description and Business Overview
Table 118. Plumbline Life Sciences Recombinant Protein Vaccine Product
Table 119. Plumbline Life Sciences Recent Development
Table 120. Novavax Corporation Information
Table 121. Novavax Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Novavax Description and Business Overview
Table 123. Novavax Recombinant Protein Vaccine Product
Table 124. Novavax Recent Development
Table . Medicago Corporation Information
Table . Medicago Description and Business Overview
Table . Medicago Recombinant Protein Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Medicago Recombinant Protein Vaccine Product
Table . Medicago Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Recombinant Protein Vaccine Distributors List
Table 133. Recombinant Protein Vaccine Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Protein Vaccine Product Picture
Figure 2. Global Recombinant Protein Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Protein Vaccine Market Share by Application in 2020 & 2026
Figure 6. Human Examples
Figure 7. Animal Examples
Figure 8. Global Recombinant Protein Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Recombinant Protein Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Recombinant Protein Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Recombinant Protein Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Recombinant Protein Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Recombinant Protein Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Protein Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Protein Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Recombinant Protein Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Protein Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Recombinant Protein Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Protein Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Recombinant Protein Vaccine Players Market Share by Revenue in Recombinant Protein Vaccine 2015 & 2019
Figure 26. Recombinant Protein Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Recombinant Protein Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Recombinant Protein Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Recombinant Protein Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Recombinant Protein Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 32. United States Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Recombinant Protein Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Recombinant Protein Vaccine Sales Market Share by Application in 2019
Figure 36. China Recombinant Protein Vaccine Sales Market Share by Company in 2019
Figure 37. China Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 38. China Recombinant Protein Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Recombinant Protein Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Recombinant Protein Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Recombinant Protein Vaccine Sales Market Share by Application in 2019
Figure 45. India Recombinant Protein Vaccine Sales Market Share by Company in 2019
Figure 46. India Recombinant Protein Vaccine Sales Market Share by Type in 2019
Figure 47. India Recombinant Protein Vaccine Sales Market Share by Application in 2019
Figure 48. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zoties Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Elanco Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Plumbline Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Novavax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Medicago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Recombinant Protein Vaccine
Figure 60. Manufacturing Process Analysis of Recombinant Protein Vaccine
Figure 61. Recombinant Protein Vaccine Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
組換えタンパク質ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Protein Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides…- 組換えハムスター卵巣細胞（CHO）B型肝炎ワクチンの世界市場レポート2020 Hepatitis B is a viral infection caused due to transmission of the virus through contact with the blood or other body fluids of an infected person. It is considered as a serious occupational hazard for healthcare professionals, which affects the liver, causing acute and chronic diseases. Hence, Chin…
- 遺伝ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Genetic Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- 組換えヒトフォリトロピンの世界市場レポート2020 A recently published report by QY Research titled Global Recombinant Human Follitropin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provid…
- 球状タンパク質の世界市場レポート2020 A recently published report by QY Research titled Global Globular Protein Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…